Company / Current Assets
Kiniksa Pharmaceuticals International, plc Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$527.2M
FY2025
5-year range
$196.4M / $527.2M
FY2021-FY2025
Trend
+58.9%
vs FY2024
Sector context
#112 of 213
Health Care
What the data says
At $527M, Kiniksa Pharmaceuticals International, plc's current assets ranks #112 of 213 in the Health Care sector. Current Assets has increased for 4 consecutive years, from $196M in FY2021 to $527M in FY2025.
Based on SEC 10-K filings.
$527M in FY2025 with a 5-year CAGR of +9.6%.
Improved from $276M to $527M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +29.4%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
#112 of 213 in Health CareTop 53% of 213This company $527.2M Sector average $2.5B
▼
-79.1% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's current assets has grown for 4 consecutive years.
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2025, current assets increased 58.9% year-over-year.
- Ranks #112 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $527.2M | +58.9% |
| FY2024 | $331.8M | +20.1% |
| FY2023 | $276.3M | +13.7% |
| FY2022 | $243.1M | +23.7% |
| FY2021 | $196.4M | -41.1% |
| FY2020 | $333.2M | +37.9% |
| FY2019 | $241.6M | -23.0% |
| FY2018 | $313.8M | +566.1% |
| FY2017 | $47.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026